Lisa is serial entrepreneur and a leader in translational neuroscience for bringing her research on axon regeneration forward to drug development. In 2011, Dr. McKerracher acquired the Cethrin program and created BioAxone BioSciences. Dr. McKerracher was co-recipient of the Christopher Reeve Medal for Spinal Cord Repair. Currently, Dr. McKerracher is an Adjunct Professor at McGill University and Université de Montréal. She brings CSO and CEO ex

Dr. Kim Anderson is an Associate Professor in the Department of Neurological Surgery at University of Miami and is focused on spinal cord injury research and bridging the gap between basic science, clinical science, and the public community living with SCI. Dr. Anderson is working with BioAxone for medical writing and preparing regulatory submissions.

Valerie Davisson brings 25 years of Wall Street, Corporate, and Public Accounting experienceShe supplements her Wall Street tenure with nearly a decade of corporate financial management at two S&P 100 manufacturing firms plus two years of public accounting at PriceWaterhouse, where she earned her CPA license. Valerie earned both a Master of Accounting and a BSBA in Finance at St. Louis University.

Dr. Bond is manages regulatory development of Cethrin. Dr. Lisa Bond has a strong science background focused on signaling pathways in mammalian cells, and she has hands-on experience with neurotrauma rehabilitation. Dr Bond earned a PhD in Clinical Biochemistry at the University of Cambridge as a Churchill Scholar and NIH Oxford-Cambridge Scholar and completed postdoctoral studies at NIH and MRC (UK).